Stefan Barth - Search Results

Year	Number of Results
2002	2
2003	4
2004	3
2005	5
2007	1
2008	5
2009	7
2010	2
2011	6
2012	8
2013	10
2014	13
2015	14
2016	17
2017	13
2018	7
2019	4
2020	6
2021	2

1

Applications of SNAP-tag technology in skin cancer therapy.

Padayachee ER, Adeola HA, Van Wyk JC, Nsole Biteghe FA, Chetty S, Khumalo NP, Barth S. Padayachee ER, et al. Among authors: barth s. Health Sci Rep. 2019 Jan 8;2(2):e103. doi: 10.1002/hsr2.103. eCollection 2019 Feb. Health Sci Rep. 2019. PMID: 30809593 Free PMC article. Review.

2

Cell-penetrating peptide enhanced insulin buccal absorption.

Xu Y, Zhang X, Wang N, Pei X, Guo Y, Wang J, Barth S, Yu F, Lee SJ, He H, Yang VC. Xu Y, et al. Among authors: barth s. Int J Pharm. 2020 Jun 30;584:119469. doi: 10.1016/j.ijpharm.2020.119469. Epub 2020 May 26. Int J Pharm. 2020. PMID: 32470482

3

Antibody-Based Immunotherapy: Alternative Approaches for the Treatment of Metastatic Melanoma.

Biteghe FAN, Chalomie NET, Mungra N, Vignaux G, Gao N, Vergeade A, Okem A, Naran K, Ndong JC, Barth S. Biteghe FAN, et al. Among authors: barth s. Biomedicines. 2020 Sep 3;8(9):327. doi: 10.3390/biomedicines8090327. Biomedicines. 2020. PMID: 32899183 Free PMC article. Review.

4

Human Granzyme B Based Targeted Cytolytic Fusion Proteins.

Hlongwane P, Mungra N, Madheswaran S, Akinrinmade OA, Chetty S, Barth S. Hlongwane P, et al. Among authors: barth s. Biomedicines. 2018 Jun 20;6(2):72. doi: 10.3390/biomedicines6020072. Biomedicines. 2018. PMID: 29925790 Free PMC article. Review.

5

Elimination of HER3-expressing breast cancer cells using aptamer-siRNA chimeras.

Nachreiner I, Hussain AF, Wullner U, Machuy N, Meyer TF, Fischer R, Gattenlöhner S, Meinhold-Heerlein I, Barth S, Tur MK. Nachreiner I, et al. Among authors: barth s. Exp Ther Med. 2019 Oct;18(4):2401-2412. doi: 10.3892/etm.2019.7753. Epub 2019 Jul 9. Exp Ther Med. 2019. PMID: 31555351 Free PMC article.

6

One-step site-specific antibody fragment auto-conjugation using SNAP-tag technology.

Hussain AF, Heppenstall PA, Kampmeier F, Meinhold-Heerlein I, Barth S. Hussain AF, et al. Among authors: barth s. Nat Protoc. 2019 Nov;14(11):3101-3125. doi: 10.1038/s41596-019-0214-y. Epub 2019 Oct 11. Nat Protoc. 2019. PMID: 31605098

7

Advances in epidermal growth factor receptor specific immunotherapy: lessons to be learned from armed antibodies.

Biteghe FAN, Mungra N, Chalomie NET, Ndong JC, Engohang-Ndong J, Vignaux G, Padayachee E, Naran K, Barth S. Biteghe FAN, et al. Among authors: barth s. Oncotarget. 2020 Sep 22;11(38):3531-3557. doi: 10.18632/oncotarget.27730. eCollection 2020 Sep 22. Oncotarget. 2020. PMID: 33014289 Free PMC article. Review.

8

Human MAP Tau Based Targeted Cytolytic Fusion Proteins.

Akinrinmade OA, Jordaan S, Hristodorov D, Mladenov R, Mungra N, Chetty S, Barth S. Akinrinmade OA, et al. Among authors: barth s. Biomedicines. 2017 Jun 27;5(3):36. doi: 10.3390/biomedicines5030036. Biomedicines. 2017. PMID: 28653985 Free PMC article. Review.

9

SNAP-tag technology: a general introduction.

Kolberg K, Puettmann C, Pardo A, Fitting J, Barth S. Kolberg K, et al. Among authors: barth s. Curr Pharm Des. 2013;19(30):5406-13. doi: 10.2174/13816128113199990514. Curr Pharm Des. 2013. PMID: 23431982 Review.

10

Targeted human cytolytic fusion proteins at the cutting edge: harnessing the apoptosis-inducing properties of human enzymes for the selective elimination of tumor cells.

Mungra N, Jordaan S, Hlongwane P, Naran K, Chetty S, Barth S. Mungra N, et al. Among authors: barth s. Oncotarget. 2019 Jan 25;10(8):897-915. doi: 10.18632/oncotarget.26618. eCollection 2019 Jan 25. Oncotarget. 2019. PMID: 30783518 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results